
NanoBio Announces Data Presentation on Its Nanoemulsion Adjuvanted RSV Vaccine at IDWeek 2012
ANN ARBOR, Mich. and SAN DIEGO (October 15, 2012) - NanoBio Corporation…

NanoBio Promotes David Peralta to Chief Executive Officer
ANN ARBOR, Mich. (October 9, 2012) - NanoBio® Corporation today…

NanoBio to Report Data on Its Nanoemulsion Adjuvanted Intranasal RSV Vaccine at the 8th Annual International Respiratory Syncytial Virus Symposium
ANN ARBOR, Mich. and SANTA FE, N.M. (September 24, 2012) - NanoBio®…

NanoBio to Present Preclinical Data on Its Nanoemulsion Adjuvanted Intranasal RSV Vaccine and Novel Inhaled Cystic Fibrosis Therapy at 52nd Annual ICAAC Meeting
ANN ARBOR, Mich. (September 10, 2012) - NanoBio Corporation announced…

A nice post
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean…
Announcements and News
- Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice
- BlueWillow Announces Promising Results for Intranasal Covid-19 Booster Vaccine
- BlueWillow Biologics Presents Positive Interim Anthrax Phase 1 Data to BARDA
Contact
BlueWillow Biologics
2311 Green Rd.
Ann Arbor, Mich. 48105
734-302-4000
734-302-9150 fax